Q9Y2Q1 (ZN257_HUMAN) Homo sapiens (Human)
Zinc finger protein 257 UniProtKBInterProSTRINGInteractive Modelling
563 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; )
It is possible new templates exist for this target since these models were created.
Sequence Features
| 173-195 | C2H2-type 1 | ||
| 201-223 | C2H2-type 2 | ||
| 229-251 | C2H2-type 3 | ||
| 257-279 | C2H2-type 4 | ||
| 285-310 | C2H2-type 5; degenerate | ||
| 316-338 | C2H2-type 6 | ||
| 344-366 | C2H2-type 7 | ||
| 372-394 | C2H2-type 8 | ||
| 400-425 | C2H2-type 9; degenerate | ||
| 431-453 | C2H2-type 10 | ||
| 459-481 | C2H2-type 11 | ||
| 487-509 | C2H2-type 12 | ||
| 515-537 | C2H2-type 13 | ||
| 3-44 | Krueppel-associated box IPR001909PF01352 | ||
| 174-195 | Zinc finger C2H2-type IPR013087PF00096 | ||
| 201-223 | Zinc finger C2H2-type IPR013087PF00096 | ||
| 229-251 | Zinc finger C2H2-type IPR013087PF00096 | ||
| 257-279 | Zinc finger C2H2-type IPR013087PF00096 | ||
| 316-338 | Zinc finger C2H2-type IPR013087PF00096 | ||
| 344-366 | Zinc finger C2H2-type IPR013087PF00096 | ||
| 372-394 | Zinc finger C2H2-type IPR013087PF00096 | ||
| 431-453 | Zinc finger C2H2-type IPR013087PF00096 | ||
| 459-481 | Zinc finger C2H2-type IPR013087PF00096 | ||
| 487-509 | Zinc finger C2H2-type IPR013087PF00096 | ||
| 515-537 | Zinc finger C2H2-type IPR013087PF00096 |
Sequence Alignments
Homology models
| Oligo-state | QMEAN | Template | Range | Seq id (%) | Ligands |
|---|---|---|---|---|---|
| monomer | -3.06 | 5v3m.1.C | 46.38 | 7×ZN; | |
| Assess | |||||
| monomer | -3.34 | 5wjq.1.C | 47.65 | 7×ZN; | |
| Assess | |||||
| monomer | -4.39 | 5wjq.1.C | 48.15 | 4×ZN; | |
| Assess | |||||
| monomer | -2.87 | 5v3m.1.C | 54.22 | 8×ZN; | |
| Assess | |||||
| monomer | -3.08 | 5v3j.1.C | 51.28 | 7×ZN; | |
| Assess | |||||
| monomer | -2.94 | 5v3m.1.C | 53.92 | 8×ZN; | |
| Assess | |||||
| monomer | -4.39 | 5wjq.1.C | 52.67 | 8×ZN; | |
| Assess | |||||
| monomer | -3.29 | 5v3m.1.C | 50.50 | 8×ZN; | |
| Assess | |||||
Homology models built on isoform sequence
| Isoform | Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | monomer | 7×ZN; | -3.11 | 5v3m.1.C | 51.43 | |
| Assess | ||||||
| Isoform 2 | monomer | 6×ZN; | -4.06 | 5wjq.1.C | 48.25 | |
| Assess | ||||||
| Isoform 2 | monomer | 6×ZN; | -3.80 | 5v3m.1.C | 45.72 | |
| Assess | ||||||
| Isoform 2 | monomer | 8×ZN; | -4.39 | 5wjq.1.C | 54.45 | |
| Assess | ||||||
| Isoform 2 | monomer | 7×ZN; | -3.39 | 5v3m.1.C | 50.16 | |
| Assess | ||||||
| Isoform 2 | monomer | 8×ZN; | -3.13 | 5v3m.1.C | 53.92 | |
| Assess | ||||||
| Isoform 2 | monomer | 8×ZN; | -3.47 | 5v3m.1.C | 50.50 | |
| Assess | ||||||
| Isoform 2 | monomer | 7×ZN; | -2.88 | 5v3j.2.C | 51.28 | |
| Assess | ||||||
| Isoform 3 | monomer | 7×ZN; | -3.43 | 5v3j.2.C | 51.02 | |
| Assess | ||||||
| Isoform 3 | monomer | 7×ZN; | -3.54 | 5wjq.1.C | 47.29 | |
| Assess | ||||||
| Isoform 3 | monomer | 7×ZN; | -3.59 | 5wjq.1.C | 48.93 | |
| Assess | ||||||
| Isoform 3 | monomer | 8×ZN; | -2.84 | 5v3m.1.C | 54.22 | |
| Assess | ||||||
| Isoform 3 | monomer | 8×ZN; | -4.41 | 5wjq.1.C | 52.67 | |
| Assess | ||||||
| Isoform 3 | monomer | 8×ZN; | -2.98 | 5v3m.1.C | 53.92 | |
| Assess | ||||||
| Isoform 3 | monomer | 7×ZN; | -2.86 | 5v3j.2.C | 51.28 | |
| Assess | ||||||
| Isoform 3 | monomer | 8×ZN; | -3.35 | 5v3m.1.C | 50.50 | |
| Assess | ||||||
| Isoform 3 | monomer | 4×ZN; | -4.51 | 5wjq.1.C | 46.15 | |
| Assess | ||||||
| Isoform 4 | monomer | 7×ZN; | -4.85 | 5v3j.2.C | 45.45 | |
| Assess | ||||||
| Isoform 4 | monomer | 7×ZN; | -3.49 | 5wjq.1.C | 47.65 | |
| Assess | ||||||
| Isoform 4 | monomer | 4×ZN; | -4.47 | 5wjq.1.C | 48.15 | |
| Assess | ||||||
| Isoform 4 | monomer | 8×ZN; | -2.88 | 5v3m.1.C | 54.22 | |
| Assess | ||||||
| Isoform 4 | monomer | 8×ZN; | -3.02 | 5v3m.1.C | 53.92 | |
| Assess | ||||||
| Isoform 4 | monomer | 7×ZN; | -3.10 | 5v3j.1.C | 51.28 | |
| Assess | ||||||
| Isoform 4 | monomer | 8×ZN; | -4.43 | 5wjq.1.C | 52.67 | |
| Assess | ||||||
| Isoform 4 | monomer | 8×ZN; | -3.44 | 5v3m.1.C | 50.50 | |
| Assess | ||||||